ATE328028T1 - Pharmazeutische zusammensetzung enthaltend polyalkylenoxide mit verringerten mengen an ameisensäure und ameisensäurederivaten - Google Patents

Pharmazeutische zusammensetzung enthaltend polyalkylenoxide mit verringerten mengen an ameisensäure und ameisensäurederivaten

Info

Publication number
ATE328028T1
ATE328028T1 AT02734076T AT02734076T ATE328028T1 AT E328028 T1 ATE328028 T1 AT E328028T1 AT 02734076 T AT02734076 T AT 02734076T AT 02734076 T AT02734076 T AT 02734076T AT E328028 T1 ATE328028 T1 AT E328028T1
Authority
AT
Austria
Prior art keywords
formic acid
reduced amounts
pharmaceutical composition
composition containing
polymers
Prior art date
Application number
AT02734076T
Other languages
English (en)
Inventor
You-Ling Fan
Original Assignee
Union Carbide Chem Plastic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Carbide Chem Plastic filed Critical Union Carbide Chem Plastic
Application granted granted Critical
Publication of ATE328028T1 publication Critical patent/ATE328028T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/30Post-polymerisation treatment, e.g. recovery, purification, drying
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/09Carboxylic acids; Metal salts thereof; Anhydrides thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polyethers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02734076T 2001-05-01 2002-04-29 Pharmazeutische zusammensetzung enthaltend polyalkylenoxide mit verringerten mengen an ameisensäure und ameisensäurederivaten ATE328028T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28788501P 2001-05-01 2001-05-01

Publications (1)

Publication Number Publication Date
ATE328028T1 true ATE328028T1 (de) 2006-06-15

Family

ID=23104789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02734076T ATE328028T1 (de) 2001-05-01 2002-04-29 Pharmazeutische zusammensetzung enthaltend polyalkylenoxide mit verringerten mengen an ameisensäure und ameisensäurederivaten

Country Status (8)

Country Link
EP (1) EP1385898B1 (de)
JP (1) JP4481569B2 (de)
AT (1) ATE328028T1 (de)
DE (1) DE60211885T2 (de)
DK (1) DK1385898T3 (de)
ES (1) ES2260437T3 (de)
IL (2) IL158620A0 (de)
WO (1) WO2002088217A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4717436B2 (ja) * 2002-04-29 2011-07-06 アルザ・コーポレーシヨン 不純物形成を減らすための、2級アミンを含む減少したギ酸ポリ(アルキレンオキシド)
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20060276620A1 (en) * 2005-06-02 2006-12-07 Nippon Shokubai Co., Ltd. Process for manufacturing a pellet-shaped nonionic alkylene oxide resin
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
JP5774853B2 (ja) 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 医薬投薬形
MX2010012039A (es) 2008-05-09 2010-11-30 Gruenenthal Gmbh Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
ES2428938T3 (es) 2009-07-22 2013-11-12 Grünenthal GmbH Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
BR112012001547A2 (pt) 2009-07-22 2016-03-08 Gruenenthal Gmbh forma de dosagem farmacêutica extrusada por fusão a quente
CN103179954A (zh) 2010-09-02 2013-06-26 格吕伦塔尔有限公司 包含阴离子聚合物的抗破碎剂型
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
PL2736497T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
WO2014191396A1 (en) 2013-05-29 2014-12-04 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
WO2015078891A1 (en) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
US20150320690A1 (en) 2014-05-12 2015-11-12 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EP3148512A1 (de) 2014-05-26 2017-04-05 Grünenthal GmbH Gegen entsorgung von ethanolischer dosis gesicherte mehrfachpartikel
BR112017021475A2 (pt) 2015-04-24 2018-07-10 Gruenenthal Gmbh forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
WO2023042533A1 (ja) * 2021-09-15 2023-03-23 住友精化株式会社 ポリアルキレンオキシド、固形製剤用組成物及びその製造方法並びに徐放性製剤用組成物
CN113945535B (zh) * 2021-12-20 2022-03-29 浙江湃肽生物有限公司南京分公司 用于测量醋酸戈舍瑞林缓释植入剂体外溶出度的方法
CN117538462B (zh) * 2024-01-10 2024-03-26 地奥集团成都药业股份有限公司 一种氨氯地平贝那普利胶囊有关物质的检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL229031A (de) * 1957-06-27
US3167519A (en) * 1958-12-29 1965-01-26 Union Carbide Corp Polymerization of epoxides
US5216122A (en) * 1991-05-21 1993-06-01 Union Carbide Chemicals & Plastics Technology Corporation Removal of residual ethylene oxide from poly(ethylene oxide)
SE9902364D0 (sv) * 1999-06-21 1999-06-21 Astra Ab New process

Also Published As

Publication number Publication date
ES2260437T3 (es) 2006-11-01
EP1385898A1 (de) 2004-02-04
JP4481569B2 (ja) 2010-06-16
DK1385898T3 (da) 2006-10-02
JP2004530748A (ja) 2004-10-07
EP1385898B1 (de) 2006-05-31
WO2002088217A1 (en) 2002-11-07
IL158620A0 (en) 2004-05-12
DE60211885D1 (de) 2006-07-06
IL158620A (en) 2010-06-30
DE60211885T2 (de) 2006-11-02

Similar Documents

Publication Publication Date Title
ATE328028T1 (de) Pharmazeutische zusammensetzung enthaltend polyalkylenoxide mit verringerten mengen an ameisensäure und ameisensäurederivaten
TW200500078A (en) Modified asialo-interferons and uses thereof
DE60131088D1 (de) Gelierende wässrige pharmazeutische zusammensetzungen
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
CY1110264T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν ευαισθητα σε ρη συμπολυμερη τυπου μπλοκ και υδροφοβο φαρμακο
WO2005034908A3 (en) A solid dosage form comprising a fibrate and a statin
EA200301250A1 (ru) Фармацевтические композиции, содержащие слаборастворимые и/или чувствительные к кислотам лекарственные средства и нейтрализованные кислотные полимеры
MXPA03008886A (es) Composiciones de baja respuesta glicemica.
BR0113663A (pt) Composições de pelìcula de pectina
BRPI0514293A (pt) sais de dicetopiperazina, sais de dicetomorfolina ou sais de dicetodioxano para administração de droga
ATE544802T1 (de) Polyglutamat-aminosäure-konjugate und verfahren
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
FR2778100B1 (fr) Nouvelles microspheres a base de poly(methylidene malonate), leur procede de preparation et compositions pharmaceutiques les contenant
ATE409185T1 (de) Chinazolin derivate
CU23318A7 (es) Composiciones farmacã0/00uticas de la tizoxanida y nitazoxanida
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
BR0208710A (pt) Composição farmacêutica antialérgica
TW200420567A (en) Quinazoline derivatives
WO2004076474A3 (en) Polyethylene glycol modified interferon compositions and methods of use thereof
DE69422532D1 (de) 2-[4-(4-Azolylbutyl)-1-piperazinyl]-5-hydroxypyrimidin-Derivate, deren Herstellung und deren Verwendung als Heilmittel
ATE406152T1 (de) Medizinische aerosolzusammensetzungen mit einer eine amid- und/oder estergruppe enthaltenden exzipientenverbindung
TNSN04077A1 (en) Linear basic compounds having nk-2 antagonist activity and formulations thereof
WO2003018690A1 (en) Composition containing fine particles for supporting biologically active substance thereon or having the same supported thereon and method for preparing these
EA200600237A1 (ru) Антипаразитарная композиция

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties